Profile
Brent Meadows served as the Chief Business Officer at Medicenna Therapeutics Corp.
in 2023 and previously held the same position at OncoOne Research & Development GmbH.
He earned an MBA from Babson College and an undergraduate degree from the University of Richmond.
Former positions of Brent Meadows
| Companies | Position | End |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Corporate Officer/Principal | 26/10/2023 |
OncoOne Research & Development GmbH
 OncoOne Research & Development GmbH BiotechnologyHealth Technology OncoOne Research & Development GmbH engages in the research in as well as the development, manufacturing, and commercialization of therapeutics, specifically in the field of oncology. It specializes in the development of drugs and novel therapeutics for the treatment of solid tumor cancers. The company was founded by Randolf Kerschbaumer, Michael Thiele, and Alexander Schinagl in June 2018 and is headquartered in Klosterneuburg, Austria. | Corporate Officer/Principal | - |
Training of Brent Meadows
| Babson College | Masters Business Admin |
| University of Richmond | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MEDICENNA THERAPEUTICS CORP. | Health Technology |
| Private companies | 1 |
|---|---|
OncoOne Research & Development GmbH
OncoOne Research & Development GmbH BiotechnologyHealth Technology OncoOne Research & Development GmbH engages in the research in as well as the development, manufacturing, and commercialization of therapeutics, specifically in the field of oncology. It specializes in the development of drugs and novel therapeutics for the treatment of solid tumor cancers. The company was founded by Randolf Kerschbaumer, Michael Thiele, and Alexander Schinagl in June 2018 and is headquartered in Klosterneuburg, Austria. | Health Technology |
- Stock Market
- Insiders
- Brent Meadows
